Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus.
Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
Diffuse Granulomatous Inflammation Associated With Long-term Interferon-β Therapy.
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job).
The role of Ets2 transcription factor in the induction of microRNA-155 by LPS, and its targeting by IL-10.
1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis.
A population-based study of fall risk factors among people with multiple sclerosis in Stockholm county.
Neuroinflammation. Contemporary anti-inflammatory treatment approaches.
Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis.
Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration.
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women.
Linear pontine trigeminal root and trigeminal nerve lesions in multiple sclerosis.
Myeloid cell-based therapies in neurological disorders: How far have we come?
Influence of Personality on the Relationship Between Gray Matter Volume and Neuropsychiatric Symptoms in Multiple Sclerosis.
Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.
Rituximab treatment did not aggravate ongoing progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.
Exercise and cognition in multiple sclerosis: The importance of acute exercise for developing better interventions.
Pegylated interferons: a nurses' review of a novel multiple sclerosis therapy.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test
Cytokine-Regulated Neutrophil Recruitment Is Required for Brain but Not Spinal Cord Inflammation during Experimental Autoimmune Encephalomyelitis.
Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
IFNγ Influences Type I Interferon Response and Susceptibility to Theiler's Virus-Induced Demyelinating Disease.
Persistence and pathogenesis of the neurotropic polyomavirus JC.
Pages
« first
‹ previous
…
402
403
404
405
406
407
408
409
410
…
next ›
last »